Veterinary and Comparative Oncology

Papers
(The H4-Index of Veterinary and Comparative Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Issue Information22
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma20
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours19
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy18
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma18
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours17
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy16
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy15
There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment15
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)14
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs13
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study13
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria12
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping12
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study12
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs12
0.0242600440979